52
views
0
recommends
+1 Recommend
2 collections
    1
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder

      research-article
      1 , 1 , 1 , 1 , 2 , 1
      Endocrinology, Diabetes & Metabolism Case Reports
      Bioscientifica Ltd
      Adult, Male, White, United Kingdom, Bone, Bone, Testosterone, GH, PTH, Thyroxine (T4), TSH, Rhabdomyolysis, Hypercalcaemia, Myositis, Hyperparathyroidism (primary), Constipation, Hypercalcaemia, Myocardial infarction, Kidney stones, Enlarged prostate, Glomerulosclerosis*, Ventricular hypertrophy, Aortic stenosis*, Hypervitaminosis A*, Oedema, Focal segmental glomerulosclerosis*, Proteinuria, Calcium (serum), Phosphate (serum), Creatinine, Creatine kinase, Estimated glomerular filtration rate, PTH, Urea and electrolytes, Vitamin D, Vitamin A*, 25-hydroxyvitamin-D3, MRI, Renal biopsy, Muscle biopsy*, CD-3*, CD-45*, Echocardiogram, Ejection fraction*, Albumin, FT4, Ultrasound scan, Histopathology, Fluid repletion, Steroids, Mycophenolate*, Pamidronate, Bisphosphonates, Prednisolone, Glucocorticoids, Lansoprazole*, Tamulosin*, Cinacalcet, Calcimimetics, Bisoprolol*, Furosemide, Nephrology, Unique/unexpected symptoms or presentations of a disease, July, 2020

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          A 53-year-old man who used growth hormone (GH), anabolic steroids and testosterone (T) for over 20 years presented with severe constipation and hypercalcaemia. He had benign prostatic hyperplasia and renal stones but no significant family history. Investigations showed – (1) corrected calcium (reference range) 3.66 mmol/L (2.2–2.6), phosphate 1.39 mmol/L (0.80–1.50), and PTH 2 pmol/L (1.6–7.2); (2) urea 21.9 mmol/L (2.5–7.8), creatinine 319 mmol/L (58–110), eGFR 18 mL/min (>90), and urine analysis (protein 4+, glucose 4+, red cells 2+); (3) creatine kinase 7952 U/L (40–320), positive anti Jo-1, and Ro-52 antibodies; (4) vitamin D 46 nmol/L (30–50), vitamin D3 29 pmol/L (55–139), vitamin A 4.65 mmol/L (1.10–2.60), and normal protein electrophoresis; (5) normal CT thorax, abdomen and pelvis and MRI of muscles showed ‘inflammation’, myositis and calcification; (6) biopsy of thigh muscles showed active myositis, chronic myopathic changes and mineral deposition and of the kidneys showed positive CD3 and CD45, focal segmental glomerulosclerosis and hypercalcaemic tubular changes; and (7) echocardiography showed left ventricular hypertrophy (likely medications and myositis contributing), aortic stenosis and an ejection fraction of 44%, and MRI confirmed these with possible right coronary artery disease. Hypercalcaemia was possibly multifactorial – (1) calcium release following myositis, rhabdomyolysis and acute kidney injury; (2) possible primary hyperparathyroidism (a low but detectable PTH); and (3) hypervitaminosis A. He was hydrated and given pamidronate, mycophenolate and prednisolone. Following initial biochemical and clinical improvement, he had multiple subsequent admissions for hypercalcaemia and renal deterioration. He continued taking GH and T despite counselling but died suddenly of a myocardial infarction.

          Learning points:
          • The differential diagnosis of hypercalcaemia is sometimes a challenge.

          • Diagnosis may require multidisciplinary expertise and multiple and invasive investigations.

          • There may be several disparate causes for hypercalcaemia, although one usually predominates.

          • Maintaining ‘body image’ even with the use of harmful drugs may be an overpowering emotion despite counselling about their dangers.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Vitamin D Toxicity–A Clinical Perspective

          Confusion, apathy, recurrent vomiting, abdominal pain, polyuria, polydipsia, and dehydration are the most often noted clinical symptoms of vitamin D toxicity (VDT; also called vitamin D intoxication or hypervitaminosis D). VDT and its clinical manifestation, severe hypercalcemia, are related to excessive long-term intake of vitamin D, malfunctions of the vitamin D metabolic pathway, or the existence of coincident disease that produces the active vitamin D metabolite locally. Although VDT is rare, the health effects can be serious if it is not promptly identified. Many forms of exogenous (iatrogenic) and endogenous VDT exist. Exogenous VDT is usually caused by the inadvertent or improper intake of extremely high doses of pharmacological preparations of vitamin D and is associated with hypercalcemia. Serum 25-hydroxyvitamin D [25(OH)D] concentrations higher than 150 ng/ml (375 nmol/l) are the hallmark of VDT due to vitamin D overdosing. Endogenous VDT may develop from excessive production of an active vitamin D metabolite – 1,25(OH)2D in granulomatous disorders and in some lymphomas or from the reduced degradation of that metabolite in idiopathic infantile hypercalcemia. Endogenous VDT may also develop from an excessive production of 25(OH)D and 1,25(OH)2D in congenital disorders, such as Williams–Beuren syndrome. Laboratory testing during routine clinical examinations may reveal asymptomatic hypercalcemia caused by the intake of vitamin D even in doses recommended for the general population and considered safe. That phenomenon, called hypersensitivity to vitamin D, reflects dysregulated vitamin D metabolism. Researchers have proposed many processes to explain VDT. Those processes include elevated activity of 1α-hydroxylase or inhibited activity of 24-hydroxylase, both leading to increased concentration of 1,25(OH)D; increased number of vitamin D receptors; and saturation of the capacity of vitamin D binding protein. Increased public awareness of vitamin D–related health benefits might increase the risk of VDT due to self-administration of vitamin D in doses higher then recommended for age and body weight or even higher than the established upper limit intake values. Consequently, the incidence of hypercalcemia due to hypervitaminosis D might increase.
            • Record: found
            • Abstract: not found
            • Article: not found

            Primary Hyperparathyroidism

              • Record: found
              • Abstract: not found
              • Article: not found

              The diagnosis and management of hypercalcaemia.

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                05 July 2020
                2020
                : 2020
                : 20-0032
                Affiliations
                [1 ]Section of Endocrinology , YYF Hospital, Ystrad Fawr Way, Caerphilly, UK
                [2 ]Centre for Endocrine and Diabetes Sciences , University Hospital of Wales, Cardiff, UK
                Author notes
                Correspondence should be addressed to R Ravindran; Email: dr.ravimrcp@ 123456gmail.com
                Author information
                http://orcid.org/0000-0003-0931-3700
                Article
                EDM200032
                10.1530/EDM-20-0032
                7354728
                90ba07f8-36fd-4a33-9847-e41d05a0f935
                © 2020 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 31 May 2020
                : 15 June 2020
                Categories
                Adult
                Male
                White
                United Kingdom
                Bone
                Bone
                Testosterone
                GH
                PTH
                Thyroxine (T4)
                TSH
                Rhabdomyolysis
                Hypercalcaemia
                Myositis
                Hyperparathyroidism (primary)
                Constipation
                Hypercalcaemia
                Myocardial infarction
                Kidney stones
                Enlarged prostate
                Glomerulosclerosis*
                Ventricular hypertrophy
                Aortic stenosis*
                Hypervitaminosis A*
                Oedema
                Focal segmental glomerulosclerosis*
                Proteinuria
                Calcium (serum)
                Phosphate (serum)
                Creatinine
                Creatine kinase
                Estimated glomerular filtration rate
                PTH
                Urea and electrolytes
                Vitamin D
                Vitamin A*
                25-hydroxyvitamin-D3
                MRI
                Renal biopsy
                Muscle biopsy*
                CD-3*
                CD-45*
                Echocardiogram
                Ejection fraction*
                Albumin
                FT4
                Ultrasound scan
                Histopathology
                Fluid repletion
                Steroids
                Mycophenolate*
                Pamidronate
                Bisphosphonates
                Prednisolone
                Glucocorticoids
                Lansoprazole*
                Tamulosin*
                Cinacalcet
                Calcimimetics
                Bisoprolol*
                Furosemide
                Nephrology
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,male,white,united kingdom,bone,testosterone,gh,pth,thyroxine (t4),tsh,rhabdomyolysis,hypercalcaemia,myositis,hyperparathyroidism (primary),constipation,myocardial infarction,kidney stones,enlarged prostate,glomerulosclerosis*,ventricular hypertrophy,aortic stenosis*,hypervitaminosis a*,oedema,focal segmental glomerulosclerosis*,proteinuria,calcium (serum),phosphate (serum),creatinine,creatine kinase,estimated glomerular filtration rate,urea and electrolytes,vitamin d,vitamin a*,25-hydroxyvitamin-d3,mri,renal biopsy,muscle biopsy*,cd-3*,cd-45*,echocardiogram,ejection fraction*,albumin,ft4,ultrasound scan,histopathology,fluid repletion,steroids,mycophenolate*,pamidronate,bisphosphonates,prednisolone,glucocorticoids,lansoprazole*,tamulosin*,cinacalcet,calcimimetics,bisoprolol*,furosemide,nephrology,unique/unexpected symptoms or presentations of a disease,july,2020

                Comments

                Comment on this article

                Related Documents Log